TALIS BIOMEDICAL CORP (TLIS) Stock Institutional Owners
TALIS BIOMEDICAL CORP (TLIS) is held by 1 institutional investors with a total value of $1.11M. This comprehensive analysis highlights the top institutional holders led by Greenlight Capital, and others, who collectively account for nearly 100% of the total institutional ownership.Greenlight Capital remains the largest institutional holder with a position worth $1.11M. Explore insights into ownership patterns, position sizes, and portfolio allocations to understand institutional investment strategies and market sentiment.
Explore more:
- TALIS BIOMEDICAL CORP (TLIS) stock institutional trading activity
- TALIS BIOMEDICAL CORP (TLIS) stock insider trading activity
- Stock rankings
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance |
|---|---|---|---|---|
| Greenlight Capital | David Einhorn | 0.05% | 149,052 | $1,110,437 |
Frequently asked questions about TLIS
Who owns the most TLIS stock?
The largest holders of TLIS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for TALIS BIOMEDICAL CORP (TLIS).
Is TLIS widely held by superinvestors?
Many widely followed stocks like TLIS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly TLIS is represented among the institutional managers we track.